About Seqster
Seqster is a company based in San Diego (United States) founded in 2016 by Xiang Li, Dana Hosseini, and Ardy Arianpour. Seqster has raised $12 million across 2 funding rounds from investors including Takeda Pharmaceuticals and Anne Wojcicki. Seqster offers products and services including Operating System for Clinical Trials, Digital Front Door, and Patient Registries. Seqster operates in a competitive market with competitors including Q Bio, Briya, Medchart, EMIS Health and Emyria, among others.
- Headquarter San Diego, United States
- Founders Xiang Li, Dana Hosseini, Ardy Arianpour
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12 M (USD)
in 2 rounds
-
Latest Funding Round
$12 M (USD), Series A
Mar 04, 2021
-
Investors
Takeda Pharmaceuticals
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Seqster
Seqster offers a comprehensive portfolio of products and services, including Operating System for Clinical Trials, Digital Front Door, and Patient Registries.
Aggregates real-time data for clinical trials and research purposes
Facilitates patient onboarding and health data access securely
Manages comprehensive health records for ongoing patient monitoring
People of Seqster
Unlock access to complete
Funding Insights of Seqster
Seqster has successfully raised a total of $12M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Seqster
Seqster has secured backing from 2 investors, including angel and institutional investors. Prominent investors backing the company include Takeda Pharmaceuticals and Anne Wojcicki.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Takeda Pharmaceuticals is engaged in developing innovative medicines globally.
|
Locked | Locked | Locked | |
|
AW
Anne Wojcicki |
Co-founder of 23andMe, prominent angel investor in health tech.
|
Locked | Locked | Locked |
Investor details for Seqster
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Seqster
Investment portfolio details for Seqster
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Seqster
Detailed financials for Seqster
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Seqster Comparisons
Peer comparison for Seqster
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Seqster
Seqster operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Q Bio, Briya, Medchart, EMIS Health and Emyria, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of clinical data management and analytics platform
|
|
| Locked | Locked | Locked |
Cloud-based tools for medical data collaboration and management are provided.
|
|
| Locked | Locked | Locked |
Cloud-based medical interoperability platform is provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Interoperability solutions for healthcare organisations are provided by EMIS Health.
|
|
| Locked | Locked | Locked |
Provider of therapy and care planning solutions using interoperable clinical data
|
Detailed competitors of Seqster
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Seqster
Complete news archive for Seqster
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seqster
Seqster was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Seqster is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Ardy Arianpour is the current CEO of Seqster. They have also founded this company.
Seqster is a funded company, having raised a total of $12M across 2 funding rounds to date.
Seqster was founded in 2016 and is headquartered in San Diego, United States. An online platform is operated in the health technology sector, where health records from multiple sources are integrated. Records for individuals and family members are stored, managed, and shared, encompassing medical details, DNA information, fitness data, and nutrition records. Operations focus on secure access and organization of personal health information.
Seqster offers Operating System for Clinical Trials, Digital Front Door, and Patient Registries.
Seqster has 2 investors. Key investors include Takeda Pharmaceuticals, and Anne Wojcicki.